t-lymphocytes

Documents about t-lymphocytes

• Controlling Hyperactive Immunity With Long-lived Lymphocytes#981396ClinicalTrials.gov
• Activated T Lymphocytes Expressing CARs, Relapsed CD19+ Malignancies Post-Allo HSCT(CARPASCIO)#1007875ClinicalTrials.gov
• Autologous IC-Nine, CD30 CAR, and Constitutive IL7R Expressing EBVST for CD30 Lymphoma (ANCILE-30)#888357ClinicalTrials.gov
• Bronchoalveolar lavage (BAL) in patients with Post-COVID-19 Syndrome (PCS). Flow cytometry and ELISA#206713RepOD Dataverse OAI Archive
• Adoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid Tumors#800555ClinicalTrials.gov
• Impact of Vitamin A on Gene Expression, in Multiple Sclerosis Patient#830824ClinicalTrials.gov
• Immune Responses to HIV in Blood Cells in HIV-Infected and HIV-Uninfected Volunteers#825155ClinicalTrials.gov
• The Collection of Peripheral Blood Lymphocytes and Marrow Progenitor Cells From Normal Volunteers and Volunteers With Lymphoid or Hematologic Malignancies#903443ClinicalTrials.gov
• Multi-virus CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRAT#830325ClinicalTrials.gov
• Allogeneic Stem Cell Transplantation With Adoptive Immunotherapy in Epstein-Barr Virus Positive Recurrent/Refractory Hodgkins Lymphoma#879581ClinicalTrials.gov
• Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus#853854ClinicalTrials.gov
• Phase I Trial of the Combination of Zidovudine and Recombinant Interleukin-2 in Patients With Persistent Generalized Lymphadenopathy#853513ClinicalTrials.gov
• Tγδ LGLL identifies a subset with more symptomatic disease: analysis of an international cohort of 137 patients#291398Gestión del Repositorio Documental de la Universidad de Salamanca
• A Clinical Imaging Study of the Changes in [18F]F-AraG Uptake Following Anti-PD-1 Therapy in Non-small Cell Lung Cancer#804906ClinicalTrials.gov
• Therapeutic Effects of Epstein-Barr Virus Immune T-Lymphocytes Derived From a Normal HLA-Compatible Or Partially-Matched Third-Party Donor in the Treatment of EBV Lymphoproliferative Disorders and EBV-Associated Malignancies#835689ClinicalTrials.gov
• Radial mobility and cytotoxic function of retroviral replicating vector transduced, non-adherent alloresponsive T lymphocytes.#683964eScholarship
• The Safety and Effectiveness of a Type of Interleukin-2 Plus Zidovudine Plus Thymosin in HIV-Positive Patients With and Without Symptoms of Infection#1032792ClinicalTrials.gov
• Image 2_Comparative efficacy and safety of traditional Chinese medicine injections combined with chemotherapy for advanced non-small cell lung cancer: a Bayesian network meta-analysis.tif#464145Figshare
• Image 1_Comparative efficacy and safety of traditional Chinese medicine injections combined with chemotherapy for advanced non-small cell lung cancer: a Bayesian network meta-analysis.tif#464146Figshare
• Effectiveness of Early or Delayed Addition of Hydroxyurea to a Three-Drug Anti-HIV Drug Combination Including Didanosine, in Advanced HIV Patients Who Failed a First or Second Anti-HIV Triple-Drug Therapy#836882ClinicalTrials.gov
• Therapeutic Allogeneic Lymphocytes and Aldesleukin in Treating Patients With High-Risk or Recurrent Myeloid Leukemia After Undergoing Donor Stem Cell Transplant#201796ClinicalTrials.gov